做多

MIRO Miromatrix Medical Price Target

Miromatrix Medical Inc. engages in the development of biological human organs to solve the chronic shortage of transplantable organs.
114,000 people in the U.S. are waiting for a life-saving organ transplant, and more than half will die due to a lack of available organs.

Miromatrix Medical trial is expected to begin in the second half of 2022 and will assess the function of a bioengineered liver in humans via an external application.

if it succeeds, the opportunity to buy the stock at these prices will be history.
The Market Cap of MIRO is just 214.74Mil

On 7/19/2021 Craig Hallum brokerage Initiated Coverage with a Buy rating and a $22.00 price target

TopgOptions

DAILY HIGH-CONVICTION OPTIONS SIGNALS patreon.com/PremiumOptionsSignals
Options buy freedom24.club/SocialBookTV
RESULTS bit.ly/TG99x
CRYPTOS partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store

此外:

免責聲明

這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。

TopgOptions

此外: